Cost cutting, new drugs boost Amgen shares
[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”27-04-2014″ enddate=”27-10-2014″ width=”300″ height=”245″] Cost cutting moves and new drugs are starting to pay off for Amgen Inc., as the biotech giant raised earnings guidance after a stronger-than-expected third quarter. The company said Oct. 27 that strong demand for its white blood cell booster, Neulasta, and increased sales of newer Read More →
Ryland shares gain on housing market performance
[wikichart align=”right” ticker=”NYSE:RYL” showannotations=”true” livequote=”true” startdate=”24-04-2014″ enddate=”24-10-2014″ width=”300″ height=”245″] Based in part on a 7.2 percent increase in third-quarter orders for new units, Westlake Village-based national homebuilder Ryland Group was trading higher Thursday after projected earnings beat Wall Street analyst expectations. Shares of Ryland Group closed at $35.78 on Oct. 23. The company reported a Read More →
Semtech earnings on track after layoffs
Shares of Camarillo-based chipmaker Semtech Corp. were up 4.8 percent after the company announced stronger-than-expected sales and profits. Semtech, which uses a fiscal year that ends in January each year, said Aug. 20 that its second-quarter fiscal 2015 revenues were $145.7 million, up 10 percent from the previous quarter but down 12 percent from the Read More →
Profits rise at PennyMac firms
Moorpark-based PennyMac Financial Services said profits rose to $51.4 million on revenue of $130.4 million for the second quarter, beating Wall Street expectations for both measures.
